The global psoriasis market is estimated to grow significantly during the forecast period. Psoriasis is a genetic condition in which skin cells build up and form scales and itchy, dry patches. It is also considered an immune system problem, that causes rashes on the skin. The primary treatment for psoriasis is medications, that aim to eliminate scales and prevent skin cells from growing rapidly. Topical ointments, light therapy, and medication can also offer relief in psoriasis itchiness.

Get Free Sample Copy @https://www.omrglobal.com/request-sample/psoriasis-drugs-market

The primary factors that drive the growth of the market include the increased incidences of psoriasis cases across the globe. As per the National Psoriasis Foundation in 2020, more than 8 million Americans suffer from psoriasis. According to the World Psoriasis Day consortium, globally 125 million people that is more than 3% of the total population suffers from psoriasis. Further, the increasing disease burden and demand for psoriasis medicines along with the rapid R&D activities in psoriasis research and pipeline drugs are some of the factors supporting the growth of the market.

Moreover, the crucial factor includes the availability of advanced treatment methods. For instance, the integration of biologics with the drugs for the treatment of psoriasis is also gaining traction. Biologics are those drugs that target only specific parts of the immune system and provides better management and control on the symptoms of psoriasis. Being effective in the treatment of moderate to severe cases of psoriasis, biologics is projected to gain traction during the forecast period and hence will enhance the growth of the market globally.

Browse for Full Report Description@https://www.omrglobal.com/industry-reports/psoriasis-drugs-market

Market Segmentation

5.1. Global Psoriasis Drugs Market by Drug Class

Tumor Necrosis Factor (TNF) Inhibitors
Interleukin Inhibitors
Vitamin D Analogs
Others
Global Psoriasis Drugs Market by Route of Administration

Oral
Parenteral
Topical
Regional Analysis

North America

United States
Canada
Europe

UK
Germany
Italy
Spain
France
Rest of Europe
Asia-Pacific

China
India
Japan
Rest of Asia-Pacific
Rest of the World
Company Profiles

AbbVie, Inc.
Amgen Inc.
AstraZeneca Plc
Bausch Health Companies Inc.
Biogen, Inc.
Boehringer Ingelheim International GmbH
Celltrion Healthcare Co. Ltd.
Dr. Reddy's Laboratories Ltd.
Eli Lilly and Co.
Johnson & Johnson Services Inc.
LEO Pharma A/S
Merck & Co. Inc.
Novartis International AG
Pfizer, Inc.
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Co. Ltd.
UCB SA
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/psoriasis-drugs-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404